Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • Overview
  • Distribution
  • Guaranteed Paid Placement
  • SocialBoost
  • Multichannel Amplification
  • All Products
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • Request More Information
  • Journalists
  • Overview
  • Distribution by PR Newswire
  • Guaranteed Paid Placement
  • SocialBoost
  • Multichannel Amplification
  • All Products
  • Request More Information
  • Journalists
  • Request More Information
  • Journalists

Pharma Indonesia and India: A Stronger Partnership In The Making
  • USA - English


News provided by

CPhI - UBM

01 Mar, 2016, 08:38 IST

Share this article

Share toX

Share this article

Share toX

Make (Pharma) in India (PRNewsFoto/CPhI - UBM)
Make (Pharma) in India (PRNewsFoto/CPhI - UBM)
Organised by UBM Malaysia (PRNewsFoto/UBM Asia)
Organised by UBM Malaysia (PRNewsFoto/UBM Asia)

JAKARTA, Indonesia, March 1, 2016 /PRNewswire/ -- Indonesia is changing at an increasing pace. New government stimuli and simplifications are being introduced with the aim, announced earlier in February by President Joko (Jokowi) Widodo, of climbing 70 positions in 2016 in the Ease of Doing Business Index (currently Indonesia ranks 109th out of 189).

Photo - http://photos.prnewswire.com/prnh/20160229/338354
Logo - http://photos.prnewswire.com/prnh/20121014/HK92339LOGO-d

Concurrently, particular emphasis has been given to the pharma sector, deemed as strategic for the country, which introduced a public health insurance scheme in 2014 and recently allowed foreign investors to own 100% of local companies.

These and other positive factors have contributed to the recent renewed upsurge in interest in the Indonesian market shown by Indian companies - which already supply almost 40% of the raw materials processed in Indonesia - that significantly increased their presence at CPhI SEA, the only trade exhibition dedicated to the pharma industry in the region. With India being the country of focus, CPhI SEA will be held at Jakarta International Expo during April 6-8, 2016 and host a pavilion organized by Pharmexcil alongside stand-alone companies like HiMedia Laboratories, Gujarat Foils and Supreem Pharmaceuticals.

Don't miss the opportunity to be part of the change, register here and join the event!

The CPhI series of events drives growth and innovation in the global pharmaceutical industry, with leading exhibitions and online communities covering every step of the supply chain from drug discovery to finished dosage.

More than 100,000 visitors meet over 6,000 exhibitors at events in Europe, China, India, Japan, South East Asia, Russia, Brazil, Istanbul and Korea every year to exchange ideas, form alliances and conduct business on an international scale. CPhI also provides an online buyer & supplier directory at CPhI-Online.com.

Media Contact:
Ivan Ferrari
Phone Number: +62 21 2930 5959 ext 138
Email: [email protected]

Related Links

http://www.cphi.com/sea/

Modal title

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.